Clinical application value of MRI-guided wire localization for non-palpable breast lesions identified on MRI only
10.3760/cma.j.cn115355-20240710-00344
- VernacularTitle:MRI导丝定位术对仅MRI显示的触诊阴性乳腺病变的临床应用价值
- Author:
Jiaqi MA
1
;
Xiufen LIANG
;
Bin YAN
;
Qiang DAI
;
Canxu SONG
;
Jiang ZHU
;
Hongbian GAO
Author Information
1. 陕西省肿瘤医院放射科，西安 710061
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Magnetic resonance imaging;
Magnetic resonance imaging-guided wire localization;
Diagnosis
- From:
Cancer Research and Clinic
2025;37(2):113-117
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the clinical application value of magnetic resonance imaging (MRI)-guided wire localization to the non-palpable breast lesions (NPBL) identified on MRI only.Methods:A retrospective case series study was conducted. A total of 171 patients with NPBL identified on MRI only who underwent MRI-guided wire localization from April 2017 to May 2024 in Shaanxi Provincial Cancer Hospital were collected. All patients had breast MRI Breast Imaging Report and Data System (BI-RADS) 4a and above lesions, and underwent MRI-guided wire localization within the same menstrual cycle within 2 days to 2 months after diagnostic MRI examination. Based on postoperative pathological results, the MRI characteristics of benign and malignant lesions were compared, and the clinical application value of MRI-guided wire localization was evaluated.Results:There were 179 lesions in 171 patients, including 54 malignant lesions (30.17%) and 125 benign lesions (69.83%). There was no statistically significant difference in the enhancement morphology between pathological benign and malignant NPBL lesions ( χ2 = 0.04, P = 0.982), while there were statistically significant differences in breast background parenchymal enhancement, lesion time-signal intensity curve and BI-RADS classification ( χ2 values were 32.03, 20.72 and 37.60, respectively, all P < 0.05). Conclusions:For NPBL that is identified on MRI only and evaluated as BI-RDADS 4a or above, MRI-guided wire localization can improve the accuracy of diagnosis and treatment of intraductal carcinoma, early invasive cancer and high-risk lesions.
